Internal Medicine · Lomita, CA
NPI
1134201791
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
24845 Narbonne Ave
Lomita, CA, 90717
Phone (310) 325-0600
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
3,400 services
Medicare patients, 2024
280
Average age 76
Drug cost, 2024
$1.2M
10,579 prescriptions
Company payments, 2025
$3,474
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nabil I El Sayad was code 99213 (office e&m - established), 1,012 times for 240 patients. In total Nabil I El Sayad billed 3,400 services in 47 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,012 | 240 | $65.25 | $66K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 457 | 155 | $0.81 | $370 |
| 82962 Clinical Chemistry | Office | 373 | 103 | $3.21 | $1,197 |
| 36415 Venipuncture Blood Collection | Office | 336 | 198 | $8.65 | $2,906 |
| 99309 SNF E&M | Facility | 291 | 21 | $84.99 | $25K |
| 99214 Office E&M - Established | Office | 210 | 118 | $96.40 | $20K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 171 | 171 | $140.20 | $24K |
| 96127 Behavioral Health Services | Office | 78 | 77 | $3.22 | $251 |
| G0008 Administration of influenza virus vaccine | Office | 70 | 65 | $35.02 | $2,451 |
| 99215 Office E&M - Established | Office | 64 | 47 | $136.71 | $8,749 |
| 90662 Vaccine Product | Office | 57 | 57 | $81.82 | $4,664 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 47 | 33 | $43.67 | $2,052 |
| 81002 Clinical Chemistry | Office | 35 | 20 | $3.41 | $119 |
| 99308 SNF E&M | Facility | 31 | 13 | $59.55 | $1,846 |
| 93000 Electrocardiogram | Office | 22 | 20 | $11.31 | $249 |
By year: 2022 $190K for 3,986 services; 2023 $165K for 3,619 services; 2024 $168K for 3,400 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 373 | 103 | $3.21 | $1,197 |
| 36415 Venipuncture Blood Collection | 336 | 198 | $8.65 | $2,906 |
| 81002 Clinical Chemistry | 35 | 20 | $3.41 | $119 |
| 88738 General Laboratory | 19 | 14 | $4.92 | $93.48 |
Medicare prescription drug claims, 2024
In 2024, the drug Nabil I El Sayad prescribed most often to Medicare patients was Atorvastatin Calcium, with 756 prescriptions and refills. In total Nabil I El Sayad wrote 10,579 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 756 | 1,779 | 208 | $9,449 |
| Losartan Potassium Generic | 450 | 1,117 | 135 | $5,059 |
| Metformin Hcl Generic | 353 | 899 | 116 | $2,995 |
| Amlodipine Besylate Generic | 334 | 759 | 85 | $2,355 |
| Rosuvastatin Calcium Generic | 294 | 860 | 104 | $5,474 |
| Levothyroxine Sodium Generic | 234 | 568 | 61 | $3,421 |
| Ibuprofen Generic | 215 | 271 | 63 | $1,785 |
| Omeprazole Generic | 199 | 518 | 70 | $2,722 |
| Tamsulosin Hcl Generic | 192 | 431 | 59 | $3,677 |
| Gabapentin Generic | 186 | 333 | 47 | $6,210 |
| Eliquis Apixaban | 183 | 266 | 31 | $122K |
| Lisinopril Generic | 175 | 480 | 62 | $1,309 |
| Famotidine Generic | 162 | 279 | 41 | $2,405 |
| Levocetirizine Dihydrochloride Generic | 158 | 433 | 76 | $5,078 |
| Furosemide Generic | 147 | 245 | 38 | $1,062 |
Brand drugs: 1,581 claims; generic drugs: 8,956 claims; opioid claims: 159.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nabil I El Sayad $3,474 ($3,474 in general payments such as food, travel and fees) from 27 companies. The largest payer was Amgen Inc. with $422.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 19 | $422 |
| Novo Nordisk Inc NVO | 16 | $345 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $340 |
| Abbvie Inc. ABBV | 14 | $329 |
| Lilly USA, LLC LLY | 10 | $316 |
| Pfizer Inc. PFE | 13 | $281 |
| GlaxoSmithKline, LLC. GSK | 8 | $194 |
| Abbott Laboratories ABT | 8 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $134 |
| Kowa Pharmaceuticals America, Inc. | 6 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.